Center of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
J Med Genet. 2019 Apr;56(4):220-227. doi: 10.1136/jmedgenet-2018-105304. Epub 2018 Jul 2.
Missense variants in , encoding a key transcriptional regulator of transforming growth factor beta signalling, were recently reported to cause arterial aneurysmal disease.
The aims of the study were to identify the genetic disease cause in families with aortic/arterial aneurysmal disease and to further define genotype-phenotype correlations.
Using gene panel sequencing, we identified a nonsense variant and four missense variants, all affecting highly conserved amino acids in the MH2 domain. The premature stop codon (c.612dup; p.(Asn205*)) was identified in a marfanoid patient with aortic root dilatation and in his affected father. A p.(Asn318Lys) missense variant was found in a Marfan syndrome (MFS)-like case who presented with aortic root aneurysm and in her affected daughter with marfanoid features and mild aortic dilatation. In a man clinically diagnosed with Loeys-Dietz syndrome (LDS) that presents with aortic root dilatation and marked tortuosity of the neck vessels, another missense variant, p.(Ser397Tyr), was identified. This variant was also found in his affected daughter with hypertelorism and arterial tortuosity, as well as his affected mother. The third missense variant, p.(Asn361Thr), was discovered in a man presenting with coronary artery dissection. Variant genotyping in three unaffected family members confirmed its absence. The last missense variant, p.(Ser467Leu), was identified in a man with significant cardiovascular and connective tissue involvement.
Taken together, our data suggest that heterozygous loss-of-function variants can cause a wide spectrum of autosomal dominant aortic and arterial aneurysmal disease, combined with connective tissue findings reminiscent of MFS and LDS.
编码转化生长因子β信号关键转录调节剂的 中的错义变异最近被报道可导致动脉瘤疾病。
本研究的目的是确定具有主动脉/动脉瘤疾病的家族的遗传疾病原因,并进一步定义 基因型-表型相关性。
使用基因panel 测序,我们鉴定了一个 无义变异和四个 错义变异,所有这些变异都影响 MH2 结构域中高度保守的氨基酸。在一个具有马凡综合征样特征的主动脉根部扩张的马凡氏综合征患者及其受影响的父亲中发现了提前终止密码子(c.612dup;p.(Asn205*))。在一个具有马凡综合征样表现的主动脉根部动脉瘤和她有马凡氏综合征样特征和轻度主动脉扩张的受影响女儿中发现了一个 p.(Asn318Lys)错义变异。在一个临床上被诊断为 Loeys-Dietz 综合征(LDS)并伴有主动脉根部扩张和颈部血管明显扭曲的男性中,另一个错义变异 p.(Ser397Tyr)被发现。该变异也在他有远视和动脉扭曲的受影响女儿以及他有受影响的母亲中发现。第三个错义变异 p.(Asn361Thr)在一个患有冠状动脉夹层的男性中被发现。对三个未受影响的家族成员进行变体基因分型证实其不存在。最后一个错义变异 p.(Ser467Leu)在一个具有显著心血管和结缔组织受累的男性中被发现。
总之,我们的数据表明,杂合性失活 变体可导致广泛的常染色体显性主动脉和动脉瘤疾病,伴有类似于 MFS 和 LDS 的结缔组织表现。